Atıf Formatları
Proteomic Profiling During Atherosclerosis Progression: Effect of Nebivolol Treatment
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

B. Ozben Et Al. , "Proteomic Profiling During Atherosclerosis Progression: Effect of Nebivolol Treatment," Balkan Clinical Laboratory Federation Congress (BCLF2013) , vol.XXI., Budva Karadag, Montenegro, pp.70, 2013

Ozben, B. Et Al. 2013. Proteomic Profiling During Atherosclerosis Progression: Effect of Nebivolol Treatment. Balkan Clinical Laboratory Federation Congress (BCLF2013) , (Budva Karadag, Montenegro), 70.

Ozben, B., Dursun, E., Monari, E., Cuoghi, A., Tomasi, A., & ÖZBEN TOMASİ, T., (2013). Proteomic Profiling During Atherosclerosis Progression: Effect of Nebivolol Treatment . Balkan Clinical Laboratory Federation Congress (BCLF2013) (pp.70). Budva Karadag, Montenegro

Ozben, Beste Et Al. "Proteomic Profiling During Atherosclerosis Progression: Effect of Nebivolol Treatment," Balkan Clinical Laboratory Federation Congress (BCLF2013), Budva Karadag, Montenegro, 2013

Ozben, Beste Et Al. "Proteomic Profiling During Atherosclerosis Progression: Effect of Nebivolol Treatment." Balkan Clinical Laboratory Federation Congress (BCLF2013) , Budva Karadag, Montenegro, pp.70, 2013

Ozben, B. Et Al. (2013) . "Proteomic Profiling During Atherosclerosis Progression: Effect of Nebivolol Treatment." Balkan Clinical Laboratory Federation Congress (BCLF2013) , Budva Karadag, Montenegro, p.70.

@conferencepaper{conferencepaper, author={Beste Ozben Et Al. }, title={Proteomic Profiling During Atherosclerosis Progression: Effect of Nebivolol Treatment}, congress name={Balkan Clinical Laboratory Federation Congress (BCLF2013)}, city={Budva Karadag}, country={Montenegro}, year={2013}, pages={70} }